Lifecare ASA: FAQ regarding Rights Issue

Reference is made to the previous stock exchange announcements published by Lifecare ASA (“Lifecare” or the “Company”) regarding the partially underwritten rights issue.

Frequently asked questions (FAQ) on the Rights Issue is avalaible in the attachment.

About us
Lifecare ASA is a clinical stage medical sensor company developing technology for sensing and monitoring of various body analytes. Lifecare’s main focus is to bring the next generation of Continuous Glucose Monitoring (“CGM“) systems to market. Lifecare enables osmotic pressure as sensing principle, combined with the ability to manipulate Nano-granular Tunnelling Resistive sensors (“NTR“) on the sensor body for read-out of pressure variations. Lifecare’s sensor technology is referred to as “Sencell” and is suitable for identifying and monitoring the occurrence of a wide range of analytes and molecules in the human body and in pets.

Contacts
For further information, please contact:

Joacim Holter, CEO, joacim.holter@lifecare.no, +47 40 05 90 40

Renete Kaarvik, CFO, renete.kaarvik@lifecare.no, +47 94 83 82 42

Attachments
FAQ Rights Issue
Lifecare ASA: FAQ regarding Rights Issue

FAQ Rights Issue
Lifecare ASA: FAQ regarding Rights Issue